Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Sheba Trial Indicates That Umbilical Cord Blood Could Help Treat Autism

Umbilical Cord Blood
Participants that have been treated for autism with cells from an umbilical cord displayed improved communication and emotional and social responsiveness.

As of today, there are around 30,000 people with autism in Israel, but the numbers are rising. About one in 100 children are diagnosed with autism, according to ALUT, the Israeli Society of Children and Adults with Autism, but the number is expected to reach one in 90 in the near future.

Umbilical cord blood is typically discarded at birth, but doctors and scientists are now calling on new mothers to collect and save the blood, that according to the latest studies could be a part of a life-changing treatment that provides hope for children with autism.

Among the institutions leading the research on the use of umbilical cord blood to treat autism is Sheba Medical Center, which is currently conducting a phase 2 trial on the subject. As part of the trial, patients receive a one-time infusion of their own cord blood cells. Initial results indicate that many patients benefited from improved communication and emotional and social responsiveness as a result of the treatment.

Dr. Omer Bar Yosef, a Sheba Medical Center neurobiologist, has thus far treated 25 children with autism as part of the Sheba trial. According to Dr. Bar Yosef, the treatment does not work for everyone, rather, “only certain subsets have shown improvement.” However, he added: “even if only 20% of those treated improve, it would be considered an amazing result.”

Hanna Abramovich-Biniachvili’s seven-year-old Avi received the treatment two years ago. Since then, Avi has been able to better control his moods and improve his interactions. “He started to speak, make eye contact,” she said. “We see such a dramatic improvement… There is a dramatic change that no previous treatment accomplished.”

Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More